Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Antiviral Res. 2017 Mar 18;142:37–54. doi: 10.1016/j.antiviral.2017.03.007

Table 1.

Reported Antiviral Activities of Bacteria-derived Antiviral Lectins.

Lectin Source Activity (nM) Cytotoxicity References
Actinohivin Longisporum albid K97-0003 HIV (2–110)
HIV-1 (0.1–160), HIV-2 (2–33), SIV (11–160), HCV
No [26, 27, 30]
Cyanovirin Nostoc ellipsosporum (0.6–7.6), HSV-1 (61.82–205), Influenza A and B (0.46–118), Ebola (40–154), & MARV (6–25) Yes [31, 32, 3441, 45, 46]
Microvirin Microcystis aeruginosa PCC7806 HIV (1.8–167) Yes [23, 48, 50]
MVL Microcystis viridis NIES-102 HIV & HCV (14–37) Yes [24, 39, 51, 52]
Scytovirin Scytonema varium HIV (0.3–187), Ebola (41), HCV (3.2–96), & MARV (260) No [8, 36, 5558]
OAA Oscillatoria agardhii NIES-204 HIV (12) Yes [6163]
PFA Pseudomonas fluorescens HIV (15) Unk [63]
MBHA Myxococcus xanthus HIV (12) Unk [63]
BOA Burkholideria oklahomensis EO147 HIV (10–24) Unk [64]

Unk - Unknown